Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Year End Trading Update

14 Nov 2017 15:45

RNS Number : 4915W
IDOX PLC
14 November 2017
 

Idox plc

("Idox", the "Company" or the "Group")

Year End Trading Update

Idox plc (AIM: IDOX), a leading supplier of specialist information management solutions and services, today provides an update on trading for its financial year ended 31 October 2017.

 

Overview

Idox continued to deliver on its strategy during the year and has grown both revenues and profits. The Company has been successful in winning several important contracts to further its focus on becoming a leading international supplier of software, services, managed services and content to the wide public sector in the UK and abroad. Due to customer disruption in the wake of June's General Election, sign-off on some contract wins, especially within health and transport have been delayed into the new financial year, resulting in an impact to 2017 profit expectations. Due to this timing impact the board now expects EBITDA for the year of about £23m, compared with £21.5m in 2016. The Board does expect completion / implementation of the contracts affected in the weeks ahead which means the Company starts 2018 with strong momentum.

In all other respects the business has made good progress in the implementation of its strategy. Public Sector and Digital Divisions have seen further adoption of our new digital solutions and we have continued to see market consolidation on our core back office products, with contracts amounting to £3.5m being awarded in the final quarter of the year. In addition, the company has been awarded the contract to deliver electronic counting of elections in Malta with an initial value of £2.1m.

 

Acquisitions

The integration of Halarose, the supplier of electoral back office software and services to UK local authorities, which Idox acquired in August is progressing well. Halarose helps create a larger, more effective and focused Idox Elections division which will increase market share through cross-selling initiatives to new and existing customers in the UK and Europe.

6PM, the healthcare solutions business acquired in January, has now been fully integrated and has been awarded contracts for 5 new NHS trusts with an order value in excess of £2.8m that we expect to be delivered in the first half of the new financial year.

 

Financial position

Group net debt ended the year at £32.7m compared with £25.1m as at 31 October 2016 and £28.2m as at 30 April 2017. The debt figure reflects acquisitions, including 6PM, and the upfront costs of the delayed contract wins.

 

Outlook

The Board remains confident that the Group is well positioned in its markets and carries excellent momentum into 2018. The Group's focus on helping public sector customers improve efficiency and effectiveness through digital transformation continues to provide considerable growth opportunities. The large proportion of annual revenue from recurring and repeating revenues and a solid order book and pipeline underpins the Group's prospects.

 

Notice of Final Results

The Board intends to report the Group's final results on 20 December 2017.

 

Andrew Riley, Chief Executive of Idox, said:

"Overall Idox has made excellent progress with its strategy of organic and acquisitive growth and our products and services continue to gain traction within our markets.

"The timing of completion of some contracts which has spilled into the new financial year gives us a strong start to 2018, we continue to keep tight control of costs and we are encouraged by the opportunities for the year ahead."

 

This announcement is released by Idox plc and contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("MAR"), encompassing information relating to the trading update described herein, and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of the Company by Andrew Riley, Chief Executive Officer.

 

 

Enquiries:

Idox plc +44 (0) 870 333 7101

Laurence Vaughan, Non-Executive Chairman

Andrew Riley, Chief Executive

Jane Mackie, Chief Financial Officer

 

N+1 Singer (NOMAD and Broker) +44 (0) 20 7496 3000

Shaun Dobson

Liz Yong

 

MHP (Financial PR) +44 (0) 20 3128 8100

Reg Hoare

Andrew Leach

Charlie Barker

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUSSVRBUAAAAA
Date   Source Headline
31st Mar 20257:00 amRNS2025 AGM Trading update
18th Mar 20259:11 amRNSHolding(s) in Company
17th Mar 20257:00 amRNSEstablishment of EBT and Total Voting Rights
13th Mar 202510:48 amRNSHolding(s) in Company
10th Mar 20253:25 pmRNSHolding(s) in Company
7th Mar 20252:39 pmRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNSPosting of Annual Report and Notice of AGM
24th Feb 20252:36 pmRNSHolding(s) in Company
24th Feb 20257:01 amRNSHolding(s) in Company
24th Feb 20257:00 amRNSHolding(s) in Company
19th Feb 20257:00 amRNSCorrection of payment date for dividend
10th Feb 20257:00 amRNSAppointment of Senior Independent Director
28th Jan 20257:00 amRNSFinal Results
14th Jan 20257:00 amRNSNotice of Final Results
6th Jan 20257:00 amRNS-RIdox Secures Election Services Contract in Malta
20th Dec 202410:43 amRNSHolding(s) in Company
26th Nov 20247:00 amRNSFull Year 2024 Trading Update
13th Nov 202411:55 amRNSHolding(s) in Company
12th Nov 202410:09 amRNSHolding(s) in Company
28th Oct 20244:49 pmRNSHolding(s) in Company
25th Oct 20247:16 amRNSDirectorate Change
27th Sep 20243:26 pmRNSHolding(s) in Company
25th Sep 20244:28 pmRNSHolding(s) in Company
23rd Sep 20244:00 pmRNSHolding(s) in Company
2nd Sep 20243:42 pmRNSHolding(s) in Company
21st Aug 20245:30 pmRNSExercise of Share Options & Total Voting Rights
7th Aug 20245:20 pmRNSHolding(s) in Company
6th Aug 20242:51 pmRNSHolding(s) in Company
29th Jul 20247:00 amRNSDirector Appointment
11th Jun 20247:00 amRNSHalf Year Results
6th Jun 20247:00 amRNSExercise of Share Options & Total Voting Rights
24th May 20243:06 pmRNSHolding(s) in Company
22nd May 20247:00 amRNSHalf Year 2024 Trading Update
9th May 20247:00 amRNSIssue and Allotment of Consideration Shares
24th Apr 20247:00 amRNSReplacement: Total Voting Rights
17th Apr 202412:43 pmRNSTotal Voting Rights
28th Mar 20245:22 pmRNSHolding(s) in Company
28th Mar 202412:37 pmRNSDirector/PDMR Shareholding
28th Mar 202411:21 amRNSResult of AGM
28th Mar 20247:00 amRNSAGM Trading update
22nd Mar 20245:42 pmRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSTotal Voting Rights
11th Mar 20248:40 amRNSHolding(s) in Company
8th Mar 20247:00 amRNSDirector/PDMR Shareholding
5th Mar 20245:12 pmRNSPosting of Annual Report and Notice of AGM
14th Feb 20241:39 pmRNSHolding(s) in Company
9th Feb 20247:00 amRNSExercise of Share Options & Total Voting Rights
25th Jan 20247:00 amRNSFinal Results
18th Jan 202412:35 pmRNSNotice of Final Results
17th Jan 20247:00 amRNSExercise of Share Options & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.